Introduction

For a buyer asking whether PYM is safe with Lexapro, Paxil, sertraline, another SSRI or SNRI, or lamotrigine, current evidence does not identify a named label interaction between those prescriptions and the active ingredients in PYM Mood Magnesium, Mood Chews, or Attention Chews. That is narrower than saying every combination is proven safe. The decision depends on the exact product, the complete prescription list, overlapping side effects, and whether lamotrigine is being used for bipolar disorder or epilepsy.

As of October 2026, current U.S. prescribing information does not identify magnesium, GABA, L-theanine, glycine, or taurine as established interactions with escitalopram, paroxetine, sertraline, venlafaxine, duloxetine, or lamotrigine. Dietary-supplement interactions are studied less consistently than drug-drug interactions, and the FDA advises discussing supplements with a doctor or pharmacist before combining them with prescriptions. FDA guidance on medications and supplements

Interaction evidence at a glance

Ingredient What human evidence establishes What remains theoretical or unstudied When prescriber sign-off matters most
Magnesium Magnesium can reduce absorption of certain antibiotics and oral bisphosphonates. No comparable absorption interaction is established for Lexapro, Paxil, sertraline, common SNRIs, or lamotrigine. No head-to-head evidence shows that glycinate, malate, citrate, or L-threonate is safer than another form with psychiatric medication. Kidney impairment, recurrent diarrhea, multiple medications, or an additional prescription known to bind minerals. NIH Office of Dietary Supplements magnesium fact sheet
GABA A U.S. Pharmacopeia safety review found no serious adverse events in the studies evaluated, but some studies reported a temporary, moderate reduction in blood pressure. Direct interaction trials with SSRIs, SNRIs, or lamotrigine are absent or too limited to guide routine combination use. Low blood pressure, antihypertensive medication, fainting, pregnancy, breastfeeding, or use with other calming or sedating substances. U.S. Pharmacopeia GABA safety review
L-theanine One six-week randomized trial combined 200 mg/day of L-theanine with 100 mg/day of sertraline; reported side-effect frequency was comparable with sertraline plus placebo. That small trial does not establish safety with Lexapro, Paxil, every sertraline dose, SNRIs, lamotrigine, pregnancy, or long-term use. Recent medication initiation or dose change, several CNS-active drugs, significant dizziness, or treatment for bipolar disorder or epilepsy. L-theanine and sertraline randomized trial
Glycine Glycine has been administered in human sleep and psychiatric research, including as an adjunct to antipsychotic treatment. The available literature does not establish its interaction profile with Lexapro, Paxil, sertraline, SNRIs, or lamotrigine. Lamotrigine used for epilepsy, complex psychiatric regimens, or a plan to take gram-level doses. Systematic review of glycine administration in adults
Taurine Human trials provide general tolerability data, but they were not designed to evaluate these psychiatric-medication combinations. An animal study found that chronic lamotrigine changed brain taurine levels, but this does not prove a harmful or beneficial interaction in humans. Lamotrigine for seizure control, blood-pressure medication, kidney disease, or multi-ingredient formulas. Preclinical lamotrigine and taurine study

What the medication labels establish

Lexapro is escitalopram, Paxil is paroxetine, and sertraline is the generic ingredient in Zoloft. These SSRIs, and SNRIs such as venlafaxine and duloxetine, carry warnings about combining them with other serotonergic substances. Examples in the labels include MAO inhibitors, tramadol, lithium, buspirone, tryptophan, and St. John’s wort. Magnesium, GABA, L-theanine, glycine, taurine, tyrosine, and acetyl L-carnitine are not named as serotonergic interaction hazards. DailyMed escitalopram prescribing information

Current PYM Mood Magnesium, Mood Chews, and Attention Chews do not contain 5-HTP, St. John’s wort, or tryptophan. That distinction matters because SSRI and SNRI labels specifically identify tryptophan and St. John’s wort as serotonergic concerns, while 5-HTP is separately cautioned with SSRIs because of its potential to increase serotonin-related effects. Memorial Sloan Kettering guidance on 5-HTP

Serotonin syndrome is not an established outcome of combining a current PYM formula with an SSRI or SNRI. Evidence is strongest, but still limited, for L-theanine with sertraline because that pairing has been tested directly. Absence from a prescription label should not be treated as blanket clearance for an unstudied dose, blend, or patient.

The more immediate practical concern is overlapping tolerability. Escitalopram, paroxetine, sertraline, SNRIs, and lamotrigine can cause dizziness, fatigue, somnolence, nausea, or impaired coordination in some people. A supplement that also makes someone sleepy, lightheaded, or nauseated may make the combined regimen harder to tolerate even without changing medication blood levels. DailyMed Paxil prescribing information

Lamotrigine is a separate decision pathway

Lamotrigine is not an SSRI or SNRI. Its major established pharmacokinetic interactions involve drugs that change glucuronidation, including valproate, certain antiseizure drugs, rifampin, and estrogen-containing contraceptives. Magnesium and the amino acids covered here are not established members of that group. DailyMed lamotrigine prescribing information

The recommendation threshold should still be higher when lamotrigine is used for epilepsy, because a poorly studied combination is harder to justify when seizure control is at stake. Starting a supplement during lamotrigine titration also complicates attribution if rash, dizziness, nausea, sleepiness, or coordination problems develop.

Magnesium forms do not create different psychiatric interaction rules

Magnesium glycinate, citrate, malate, oxide, and L-threonate all supply magnesium, but differ in compound weight, solubility, elemental magnesium content, gastrointestinal tolerance, and the amount required per serving. The Supplement Facts panel reports elemental magnesium rather than the full weight of the magnesium compound.

Form Practical distinction Medication-combination implication
Magnesium glycinate or bisglycinate Commonly selected when gastrointestinal tolerance is a priority. No direct evidence establishes a unique advantage with SSRIs, SNRIs, or lamotrigine.
Magnesium citrate Relatively soluble; loose stools can become dose-limiting. Diarrhea can affect routine adherence and hydration but is not proof of a psychiatric-drug interaction.
Magnesium malate Supplies magnesium bound to malic acid. Interaction evidence with the named medications remains thin.
Magnesium L-threonate Studied separately for cognitive and sleep outcomes; it typically provides less elemental magnesium per gram of compound. Brain-oriented marketing does not establish superior compatibility with psychiatric medication.
Magnesium oxide Provides substantial elemental magnesium by weight but is generally less bioavailable than several more soluble forms. Form does not remove kidney, gastrointestinal, or known mineral-binding precautions.

For interaction screening, total elemental magnesium, kidney function, other medications, and actual side effects usually matter more than whether the label says glycinate, malate, or L-threonate. NIH guidance on magnesium forms and bioavailability

Does magnesium need to be separated from psychiatric medication?

There is no evidence-based universal rule requiring magnesium to be taken two hours away from Lexapro, Paxil, sertraline, venlafaxine, duloxetine, or lamotrigine. Current prescribing information permits escitalopram, paroxetine, sertraline, and lamotrigine to be taken without a mineral-specific separation instruction. DailyMed Zoloft prescribing information

Magnesium separation is established for other medication categories. Tetracycline and quinolone antibiotics should be taken at least two hours before or four to six hours after a magnesium supplement. Oral bisphosphonates should be separated from magnesium by at least two hours. A pharmacist should review the entire medication list rather than only the psychiatric prescription.

A two-hour gap may still be used as a conservative troubleshooting strategy when a clinician agrees, especially when introducing one new ingredient. It can help identify which item caused nausea or loose stools, but timing does not prevent additive sleepiness, dizziness, blood-pressure effects, or other pharmacodynamic interactions.

Combinations that warrant prescriber or pharmacist sign-off

  • Any supplement during lamotrigine titration: avoid creating uncertainty around rash, dizziness, nausea, coordination changes, or somnolence.
  • Lamotrigine used for epilepsy: seizure control raises the consequence of relying on thin interaction evidence.
  • A recently started or increased SSRI or SNRI: establish the medication’s baseline effects before adding another CNS-active ingredient.
  • Several calming ingredients in one formula: GABA, L-theanine, glycine, taurine, magnesium, antihistamines, cannabis, alcohol, and sleep medication can make cause and effect difficult to identify.
  • Kidney impairment: reduced magnesium clearance increases the risk from excessive supplemental magnesium.
  • Low blood pressure or antihypertensive treatment: GABA has produced temporary blood-pressure reductions in some studies, and taurine may also affect blood pressure.
  • Pregnancy or breastfeeding: combination data are inadequate, particularly for supplemental GABA.
  • Older adults with fall risk or polypharmacy: dizziness, sedation, diarrhea, and blood-pressure changes may matter more than the absence of a named interaction.

Questions to bring to a doctor or pharmacist

  1. Does the exact PYM product, ingredient amount, and serving size interact with my complete medication list, including prescriptions, antihistamines, sleep aids, antacids, antibiotics, and blood-pressure drugs?
  2. Does the recommendation change because lamotrigine is being used for epilepsy rather than bipolar disorder?
  3. Should I wait until my current medication dose has been stable before trying the supplement?
  4. Does my kidney function change the amount of supplemental magnesium that is reasonable?
  5. Should I separate this product from any medication, and what spacing interval is supported for that specific drug?
  6. Would starting with one ingredient instead of a multi-ingredient blend make adverse effects easier to identify?
  7. Which symptoms mean I should stop the supplement, and which require urgent medical care?

Symptoms that should not be treated as routine adjustment

Seek prompt medical guidance for fainting, severe dizziness, marked confusion, new coordination problems, or persistent vomiting or diarrhea. A new rash while taking lamotrigine requires urgent clinical assessment rather than self-directed experimentation with timing or dose.

Agitation, confusion, fever, heavy sweating, diarrhea, tremor, muscle rigidity, or abnormal reflexes can be signs of serotonin syndrome in someone taking an SSRI or SNRI. Current PYM ingredients are not established causes of serotonin syndrome, but urgent symptoms should be evaluated based on the complete regimen rather than assumptions about which ingredient is responsible. DailyMed Effexor XR interaction guidance

PYM products with Lexapro, Paxil, SNRIs, lamotrigine and other prescriptions

The product name changes the medication review because the three current PYM formulas use different combinations and amounts. Mood Magnesium creates the clearest mineral-absorption timing question. Mood Chews centers the review on GABA and L-theanine. Attention Chews adds tyrosine, acetyl L-carnitine, taurine, glycine, zinc, and B vitamins, so it should not be evaluated as though it were another GABA formula.

Current active ingredients and medication considerations as of October 2026. Amounts are per scoop or chew as listed on the product labels.
PYM product Active ingredients Lexapro, Paxil, sertraline and other SSRIs or SNRIs Lamotrigine Other documented medication considerations
PYM Mood Magnesium 250.5 mg total elemental magnesium from magnesium L-threonate, magnesium glycinate, and magnesium malate; 500 mg glycine; 100 mg L-theanine; 5 mg vitamin B6. No established label interaction is identified. L-theanine has limited direct combination evidence with sertraline, but the complete Mood Magnesium formula has not been tested with Lexapro, Paxil, or an SNRI. Watch for overlapping nausea, dizziness, fatigue, or sleepiness. No ingredient is established to alter lamotrigine glucuronidation. Starting the formula during lamotrigine titration can make rash, dizziness, nausea, sleepiness, or coordination changes harder to attribute. Magnesium can reduce absorption of oral bisphosphonates and tetracycline or quinolone antibiotics. Kidney impairment increases the importance of clinician review.
PYM Mood Chews 130 mg GABA and 90 mg L-theanine per chew. GABA and L-theanine are not established serotonin-syndrome triggers. L-theanine has limited direct evidence with sertraline, while GABA lacks comparable SSRI or SNRI combination trials. GABA can temporarily lower blood pressure in some people. No established pharmacokinetic interaction is identified, but the combination has not been directly studied. Prescriber sign-off matters most during titration or when lamotrigine is used for epilepsy. Review is especially important with antihypertensive drugs, sleep medication, sedating antihistamines, alcohol, cannabis, or another calming supplement.
PYM Attention Chews 518 mg acetyl L-carnitine HCl; 54 mg tyrosine; 11 mg taurine; 2 mg L-theanine; 107 mg glycine; 1.3 mg zinc glycinate; 1 mg vitamin B6; 0.7 mcg vitamin B12. The active ingredients are not named serotonergic hazards in SSRI or SNRI prescribing information, but the complete formula has not been directly tested with these medications. Review the whole formula rather than assuming that evidence for L-theanine alone applies to the blend. No established interaction with lamotrigine is identified. The multi-ingredient formula can still complicate assessment of dizziness, nausea, sleep changes, or coordination symptoms. Zinc can reduce absorption of tetracycline and quinolone antibiotics when taken together and can interfere with penicillamine. A pharmacist can set the correct spacing interval for the named prescription.

The mineral-timing issue is separate from the serotonin question. Magnesium in Mood Magnesium has established absorption interactions with oral bisphosphonates and certain antibiotics, and zinc in Attention Chews has its own antibiotic and penicillamine considerations. Those are gastrointestinal binding issues, not evidence that PYM increases serotonin. NIH magnesium interaction guidance NIH zinc interaction guidance

The strongest directly relevant psychiatric-medication evidence remains a small trial of L-theanine with sertraline. GABA has general human safety data, including a documented potential for temporary blood-pressure reduction, but lacks equivalent SSRI, SNRI, or lamotrigine combination trials. L-theanine and sertraline trial U.S. Pharmacopeia GABA review

Side effects, allergens and reasons to avoid or delay a PYM product

  • Mood Magnesium: supplemental magnesium can cause diarrhea, nausea, or abdominal cramping. Do not start it without clinician review if kidney function is impaired.
  • Mood Chews: GABA can temporarily lower blood pressure. A buyer who already takes an antihypertensive drug can identify that prescription and ask specifically about additive lightheadedness or fainting.
  • Attention Chews: the formula contains eight listed actives, so it is harder to identify the cause of a new symptom than it would be with a single-ingredient supplement.
  • Food-allergy review: current Mood Chews and Attention Chews labels state that they are manufactured in a facility producing products with milk, tree nuts, wheat, and soy. This is a shared-facility statement, not a declaration that those allergens are active ingredients.
  • Children, pregnancy and breastfeeding: current chew labels direct buyers to consult a physician during pregnancy or breastfeeding, and the chew products are not recommended for children under 14.
  • Lamotrigine titration: delay a new multi-ingredient supplement until the prescriber approves it, because a new rash or neurological symptom requires a clear clinical assessment.

Mood Magnesium is labeled vegan and gluten-free; its other ingredients are citric acid, inulin, silicon dioxide, organic flavor, and rebaudioside A from stevia. Mood Chews use pectin rather than gelatin and list tapioca syrup, erythritol, water, flavoring, citric acid, monk fruit extract, and calcium citrate among their other ingredients. Buyers with severe food allergies should check the package for the exact flavor and lot before use.

No PYM product, or any other calming supplement, should be treated as a substitute for an SSRI, SNRI, lamotrigine, or individualized psychiatric care. Before the first dose, give the exact Supplement Facts panel and complete medication list to the prescriber or pharmacist and ask for a product-specific decision.

Frequently asked questions

Is PYM safe to take with Lexapro, Paxil, sertraline, or another SSRI or SNRI?

No established interaction in current U.S. prescribing information automatically rules out PYM Mood Magnesium, Mood Chews, or Attention Chews with Lexapro, Paxil, sertraline, or common SNRIs. Current PYM formulas also do not contain 5-HTP, St. John’s wort, or tryptophan. The unresolved issue is that complete PYM formulas have not been directly tested with every antidepressant, dose, and medical history. A prescriber or pharmacist should review the exact product and the buyer’s complete medication list before use.

Does L-theanine increase serotonin-syndrome risk with an SSRI or SNRI?

L-theanine is not established as a serotonin-syndrome trigger, and one small randomized trial combined 200 mg/day with sertraline without finding a higher frequency of side effects than sertraline plus placebo. That study does not clear every SSRI, SNRI, dose, blend, or medical history. Urgent symptoms such as agitation, fever, heavy sweating, tremor, rigidity, confusion, or abnormal reflexes still require evaluation of the complete regimen.

Should PYM Mood Magnesium be taken two hours away from lamotrigine?

A two-hour separation from lamotrigine is not supported by an established magnesium-binding interaction. Lamotrigine’s major known interactions involve drugs that alter glucuronidation rather than mineral chelation. A clinician may still recommend spacing for tolerability or troubleshooting, but separation should not be presented as a proven way to prevent an unstudied interaction. Starting Mood Magnesium during lamotrigine titration deserves separate approval because both regimens can produce symptoms that require clear attribution.

Which PYM products need to be separated from antibiotics or bisphosphonates?

PYM Mood Magnesium creates the clearest spacing requirement because magnesium can reduce absorption of tetracycline antibiotics, quinolone antibiotics, and oral bisphosphonates. Attention Chews contain zinc, which can also interfere with tetracycline or quinolone antibiotics and penicillamine. Mood Chews do not contain magnesium or zinc. Ask the pharmacist about the named prescription because recommended spacing differs by medication and mineral.

Is it sensible to start a PYM product during lamotrigine titration?

Prescriber approval should come before starting a PYM product during lamotrigine titration, especially a multi-ingredient formula. Lamotrigine can cause serious rash as well as dizziness, nausea, somnolence, and coordination problems. Adding several ingredients at once makes it harder to identify whether a new symptom comes from lamotrigine, the supplement, or the combination. A new rash while taking lamotrigine requires urgent clinical assessment rather than a self-directed change in supplement timing.

What side effects, allergens, or reasons to avoid PYM should buyers know about?

Mood Magnesium can cause diarrhea, nausea, or abdominal cramping and requires added caution with kidney impairment. Mood Chews contain GABA, which has produced temporary blood-pressure reductions in some studies. Mood Chews and Attention Chews carry shared-facility statements for milk, tree nuts, wheat, and soy. The chew products are not recommended for children under 14, and their labels direct pregnant or breastfeeding buyers to consult a physician. The exact package label should guide an allergy review.

References